State Directory

Provider Records in Missouri

GLP1Search tracks 241 provider records across 65 Missouri cities. 1 records include explicit GLP-1, medication, or peptide treatment evidence; 240 are directory-only healthcare/provider records that need direct confirmation.

Provider Records

241

Cities

65

Treatment Evidence

1

Directory-Only

240

Market Snapshot

Where source-ready GLP-1 records are concentrated in Missouri

The Missouri source-ready local index is led by its largest indexed cities. Across the state, 98% of provider records include phone plus address or website coverage, 0% list public pricing, and 76% carry an upstream source/place signal.

Data Complete

98%

Pricing Visible

0%

Source Flagged

76%

Top Missouri cities for source-ready GLP-1 records

All covered cities in Missouri

Arnold1
Ballwin1
Bloomsdale1
Blue Springs3
Bolivar1
Branson2
Brentwood1
Bridgeton1
Camdenton2
Cape Girardeau2
Cassville1
Chesterfield11
Columbia14
Creve Coeur6
Des Peres2
Dexter1
Ellisville1
Eureka1
Excelsior Springs1
Farmington3
Fenton1
Festus1
Fort Leonard Wood1
Frontenac1
Hannibal2
Harrisonville1
High Ridge1
Independence2
Jefferson City8
Joplin1
Kansas City53
Kirkwood1
Lake Ozark2
Lake St Louis3
Lebanon1
Lee's Summit14
Liberty1
Manchester1
Marshfield1
Moberly1
Nevada1
New Melle1
O'Fallon9
Osage Beach8
Owensville1
Parkville1
Pineville1
Platte City1
Rolla4
Sedalia1
Sikeston2
Springfield13
St James1
St Joseph1
St Robert2
St. Louis27
Steele1
Sullivan2
Thayer1
Town and Country1
University City1
Warrensburg1
Washington3
Waynesville1
Wentzville3

Questions about provider records in Missouri

How many providers are listed?

GLP1Search lists 241 provider records across 65 cities in Missouri, including 1 treatment-evidence records and 240 directory-only records to verify.

Which cities have the most listings?

Kansas City (53), St. Louis (27), Columbia (14), Lee's Summit (14), Springfield (13) currently have the highest listing density in Missouri.

What should patients compare?

Compare licensed clinical oversight, medication source, pharmacy type, public pricing, follow-up cadence, side-effect support, and whether the clinic documents semaglutide or tirzepatide availability.